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Introduction: Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a 
recently identified neurodegenerative disorder caused by the expansions of 
CGG repeats (55-200 CGG) in the non-coding region of the Fragile X mental 
retardation 1 gene [1]. A knock-in mouse model with a (CGG)98 repeat in the 
permutation range has been generated and used as a model for FXTAS [1]. 
In this mouse model, intranuclear inclusions characteristics of FXTAS were 
detected in neurons and astrocytes in the cortex, brainstem and with the 
highest density in hippocampus. Despite the presence of intranuclear inclu-
sions and the description of a mild phenotype, no brain lesion or structural 
abnormality has been described. The aim of this study is to investigate the 
longitudinal changes in neurochemical profile of the FXTAS knock-in mice 
in vivo using 1H MRS.
Subjects and Methods: Male FXTAS knock-in mice (C57BL/6J background, 
n = 7) [1] and male WT littermates (n = 7) were anesthetized with 1.5-2% 
isoflurane during MRS measurement. In vivo MRS experiments were per-
formed on a 14.1T/26cm magnet (Agilent/Magnex). Short-TE MRS se-
quence, SPECIAL[2] (TE = 2.8ms, TR = 4s) was used to measure 1H NMR 
spectra in hippocampus and cerebellum at the age of 5 months, 12 months 
and 18 months. Metabolite concentrations were quantified by LCModel [3] 
using water as a reference.
Results and Discussion: At the age of 5 months (no behavioral alterations 
[1]), metabolites concentrations measured in hippocampus and cerebellum 
of FXTAS knock-in mice show similar pattern as those of WT mice (not 
shown). However, an increased trend of PCr was observed in both cerebel-
lum (p=0.086) and hippocampus (p=0.07) (Fig. 1), which was also noticed 
in the in vivo spectra and continued in hippocampus at the age of 12 and 
18 months (Fig. 2). Furthermore, at the age of 18 months, compared to WT 
mice, the FXTAS mice displayed a decrease of myo-inositol (-9%, p=0.008) 
and lactate (-39%, p =0.008) in hippocampus, an increase of GABA (+18%, 
p=0.08) and a decrease of glutamine (-15%, p=0.04) in cerebellum (Fig. 1).
We conclude that there are merely weak changes in metabolites concentra-
tions between the FXTAS mice and WT mice. The elevated trend of PCr in 
hippocampus might be an early indication of FXTAS prior to the formation 
of inclusions, which should be further validated by 31P spectroscopy.
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